Edward Doyle

Lack of evidence for metabolism of p-phenylenediamine by human hepatic cytochrome P450 enzymes

Lesley A. Stanley, Julie A. Skare, Edward Doyle et al. · Toxicology · 2005 · 58 citations

Biochemistry, Medicine, Liver Physiology +9

Phase I and Pharmacologic Study of the Combination of Paclitaxel, Cisplatin, and Topotecan Administered Intravenously Every 21 Days as First-Line Therapy in Patients With Advanced Ovarian Cancer

Virginie M.M. Herben, Vinodh R. Nannan Panday, Dick J. Richel et al. · Journal of Clinical Oncology · 1999 · 43 citations

O-glucuronidation, a newly identified metabolic pathway for topotecan and N-desmethyl topotecan

Hilde Rosing, Desir e M van Zomeren, Edward Doyle et al. · Anti-Cancer Drugs · 1998 · 40 citations

Clinical Urine Samples, Engineering, Aldo-keto Reductase +22

In Vitro Activity of Gemifloxacin (SB-265805, LB20304a) against <i>Legionella pneumophila</i> and Its Pharmacokinetics in Guinea Pigs with <i>L. pneumophila</i> Pneumonia

Paul H. Edelstein, Takashi Shinzato, Edward Doyle et al. · Antimicrobial Agents and Chemotherapy · 2001 · 27 citations · Full text

Terminal Half-life Phase, Static Activity, Antimicrobial Chemotherapy +16

Metabolism of deltamethrin and <i>cis</i>- and <i>trans</i>-permethrin by human expressed cytochrome P450 and carboxylesterase enzymes

Laura Hedges, Susan J. Brown, Annette MacLeod et al. · Xenobiotica · 2018 · 24 citations